|
Aug 12
|
Are Options Traders Betting on a Big Move in BCRX Stock?
|
|
Aug 11
|
BioCryst Announces Departure of Dr. Helen Thackray
|
|
Aug 5
|
BioCryst Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 5
|
BioCryst Pharmaceuticals Inc (BCRX) Q2 2025 Earnings Call Highlights: Record ORLADEYO Revenue ...
|
|
Aug 4
|
BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
|
|
Aug 4
|
BioCryst: Q2 Earnings Snapshot
|
|
Aug 4
|
BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update
|
|
Jul 31
|
BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock
|
|
Jul 31
|
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December
|
|
Jul 29
|
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 28
|
BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Jul 21
|
BioCryst to Report Second Quarter 2025 Financial Results on August 4
|
|
Jul 15
|
AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies
|
|
Jun 27
|
Sector Update: Health Care Stocks Retreat Late Afternoon
|
|
Jun 27
|
Sector Update: Health Care Stocks Mixed Friday Afternoon
|
|
Jun 27
|
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid China Trade Deal Optimism
|
|
Jun 27
|
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
|
|
Jun 26
|
Zacks.com featured highlights ASR, INSW, BCRX, ASC and RRGB
|
|
Jun 25
|
BioCryst (BCRX) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
|
Jun 13
|
Sector Update: Health Care Stocks Lean Lower Premarket Friday
|